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Abstract
The heart is the first organ to form during embryonic development. Given the complex nature of 
cardiac differentiation and morphogenesis, it is not surprising that some form of congenital heart 
disease is present in approximately one percent of newborns. The molecular determinants of heart 
development have received much attention over the past several decades. This has been driven in 
large part by an interest in understanding the etiology of congenital heart disease coupled with the 
potential of utilizing knowledge from developmental biology to generate functional cells and 
tissues that could be used for regenerative medicine purposes. In this review, we highlight the 
critical signaling pathways and transcription factor networks that regulate cardiomyocyte lineage 
specification in both in vivo and in vitro models. Special focus will be given to epigenetic 
regulators that drive the commitment of cardiomyogenic cells from nascent mesoderm and their 
differentiation into chamber-specific myocytes as well as regulation of myocardial trabeculation.
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Introduction
Molecular regulation of heart formation has fascinated biologists for more than a century. 
Driven by both the need for greater understanding of the etiology of congenital heart disease 
and its potential in regenerative medicine, investigators in cardiac developmental biology 
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have devoted significant efforts in recent years to address fundamental mechanisms that 
underlie the complex patterning of the developing heart. In this review, we aim to 
summarize succinctly the critical regulators of this process. In particular, we focus on 
interactions between signaling molecules and transcription factor networks during 
cardiomyocyte lineage commitment and myocardial chamber specification. Furthermore, we 
highlight recent articles in this area and draw particular attention to epigenetic factors that 
play a role in these processes. For a detailed discussion of earlier works on this topic, we 
recommend several excellent reviews that address myocardial development in different 
model organisms including mouse, fish, frogs, and chick.1, 2 We hope this article will inform 
and inspire greater interest in cardiac development among investigators in cardiovascular 
biology and spur new collaborations between basic and clinical scientists interested in 
congenital heart disease.
Overview of Morphological Development
The following overview is intended to orient the reader with respect to major morphological 
processes that will be discussed in further detail in subsequent sections. The heart is formed 
from bilateral heart fields that are established during the gastrulation process (see Figure 1). 
The heart field precursors migrate anteriorly and laterally from the primitive streak to form 
the antero-lateral plate mesoderm which undergoes rapid migration towards the midline. 
Subsequent fusion at the midline, led by closure of the foregut,3 gives rise to the linear heart 
tube. Notably, elongation of the heart tube occurs primarily via addition of second heart 
field (SHF)-derived cardiomyocytes to both poles, producing an embryonic organ that 
consists of the truncus arteriosus most cranially followed by the bulbus cordis, ventricle, 
atrium and sinus venosus. It is at this stage that the heart becomes functional as blood is 
pumped from the venous pole to the arterial pole.4 The heart’s ability to generate blood flow 
at this stage is critical to the continuation of cardiogenesis and to other processes in 
embryogenesis that respond to hemodynamic signals.5–9 The process of rightward looping 
occurs in conjunction with the addition of the SHF cells to both poles of the linear heart 
tube. Concurrently, the developing atria migrate and become cranially positioned relative to 
the ventricles. Complex remodeling, selective proliferation, myocardial subpopulation 
specification, septation, and valve development then result in the formation of the four-
chambered heart.
Specification of cardiac mesoderm and formation of the cardiac crescent
During gastrulation, the three primary germ layers are formed with mesoderm sandwiched 
between ventral endoderm and dorsal ectoderm. Myocardial precursor cells expressing the 
T-box transcription factor T (Brachyury) migrate from the posterior epiblast through the 
anterior portion of the primitive streak. These cells subsequently move laterally and, as the 
embryonic coelom forms, will occupy bilateral regions of lateral splanchnic mesoderm that 
is adjacent to underlying endoderm.10 The population of cardiac progenitor cells then 
converges at the midline and organizes into a crescent, with the peak of the crescent located 
cranially and the tails of the crescent extending caudally. Pro-cardiogenic signals from 
underlying foregut endoderm and anti-cardiogenic signals from midline structures and the 
neural plate determine the precise size and shape of the heart fields (Figure 2).10
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A cascade of transcription factor activation ultimately results in cardiac specification and 
differentiation. During the primitive streak stage of mouse embryonic development, the T-
box transcription factor Eomesodermin (Eomes) activates the basic helix-loop-helix 
transcription factor Mesoderm Posterior 1 (Mesp1).11, 12 Mesp1 expression at the start of 
gastrulation represents the first known molecular step towards cardiogenesis. Mesp1 and 
family member Mesp2 are the earliest markers of cardiovascular specification in the 
developing embryo.13 The mechanism by which Mesp1 promotes cardiac specification is 
multi-faceted in that Mesp1 drives expression of cardiac transcription factors while also 
repressing genes that maintain pluripotency.14 As cardiac precursors migrate away from the 
primitive streak to form the cardiac crescent, they down-regulate Mesp1 and Mesp2 while 
activating other transcription factor networks that drive cardiac specification.
Among the pro-cardiogenic factors expressed in endoderm and mesoderm are Hedgehog, 
bone morphogenetic proteins (BMPs)15, 16, fibroblast growth factors (FGFs), and non-
canonical Wnt/JNK.17 Canonical Wnt ligands, including Wnt1 and Wnt3a, secreted from the 
neural tube inhibit cardiac mesoderm specification18, as do BMP antagonists Noggin and 
Chordin secreted from the notochord. Canonical Wnt/β-catenin inhibitors, including Dkk-1 
and crescent, are also secreted by the endoderm underlying cardiac mesoderm and serve to 
counteract the inhibitory Wnt signals emanating from the neural plate.19, 20 Interestingly, 
selective elimination of canonical Wnt/β-catenin signaling in endoderm via deletion of β-
catenin results in formation of ectopic cardiac tissue in overlying mesoderm.21 The 
mechanism by which inhibition of Wnt/β-catenin signaling in endoderm induces cardiac 
specification is thought to be due to activation of the homeodomain transcription factor Hex 
in endoderm.22 Notably, Hex is associated with induction of cardiac transcription factors 
such as Nkx2-5 and Tbx5 but does not directly activate expression of cardiac contractile 
genes, such as those encoding myofilament proteins.22
First and Second Heart Fields
The earliest cells to express Mesp1 form the first heart field (FHF), which makes up the 
cardiac crescent. A later wave of Mesp1 produces cardiac progenitors of the second heart 
field (SHF), which are derived from pharyngeal mesoderm and lie anterior and medial to the 
cells of the FHF.23–26 Clonal analysis in mice suggests that these progenitor cells are 
committed to the FHF or SHF early, likely prior to the onset of Mesp1 expression.27 As the 
cells of the FHF differentiate and proliferate during the formation of the linear heart tube, 
the cells of the SHF retain their undifferentiated myocardial progenitor identity and become 
positioned dorsally relative to the heart tube28. Lineage tracing studies in both chick and 
mouse embryos have demonstrated that the cells of the FHF contribute primarily to the left 
ventricle with small contributions to the atria while the SHF will form the right ventricle, 
outflow tract, atria and inflow myocardium (see Figure 3).24, 25, 29–32 Within the SHF, 
progenitor cells that will give rise to the right ventricle and outflow tract are considered 
anterior SHF, while precursors of the atria and inflow tract are termed posterior SHF.33 SHF 
progenitors demonstrate increased proliferation and delayed differentiation compared to 
their FHF counterparts34 and differentiate as they contribute to both the venous and arterial 
poles of the linear heart tube, promoting its elongation.
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The FHF cells are identified by the expression of Tbx5 and the first wave of Nkx2-5.35, 36 
Recently, early expression of ion channel gene HCN4 was also reported to be FHF-specific, 
leading to identification of the atrioventricular (AV) node and parts of the early conduction 
system as FHF-derived structures.37, 38 Of note, early FHF-specific HCN4 expression is 
distinct from later expression in the cardiac conduction system and sinoatrial node.37 The 
second heart field is marked by expression of the LIM homeodomain transcription factor 
Islet1 (Isl1).31, 35, 39 Recently, expression of Tbx1 in the second heart field was shown to 
coordinate SHF contribution to the two poles of the linear heart tube.40 Other genes 
expressed in SHF progenitor cells include Prdm1, Pitx2, Six1, Fgf8, and 
Fgf10.28, 31–33, 41, 42 As cardiac differentiation progresses during addition of SHF cells to 
the linear heart tube, these genes will be down-regulated as the next wave of cardiac 
transcription factors becomes activated, including Nkx2-5, Gata4 and Mef2c.24, 32 A 
summary of the key transcription factor interactions that regulate FHF and SHF 
differentiation is shown in Figure 4.
In both human and mouse embryonic stem (ES) cell models, Isl1-expressing cells have been 
shown to give rise to cardiomyocytes as well as smooth muscle cells and endothelium 
(Figure 3).39, 43 The existence of a multipotent Isl1+ progenitor cell in vivo is postulated 
from the contribution of Isl1-expressing SHF to the smooth muscle cells of the great vessels 
(aorta and pulmonary trunk) and endothelial cells of the proximal coronary artery. However, 
limited data exist to support the diversification of cardiovascular lineage cells from a single 
Isl1+ cell. Nevertheless, a population of Isl1+ progenitors has been identified in both mouse 
and human hearts in the fetal and early postnatal stages.43, 44 Reportedly, these cells 
represent residual SHF progenitor cells given the significant decline in the number of these 
cells after early fetal development and the absence of these cells in the adult heart. The 
potential that these cells may participate in myocardial injury repair has motivated a number 
of investigators to examine the presence of Isl1+ cells in the heart after infarction.45 Thus 
far, no reactivation of Isl1+ cells or their contribution to new cardiomyocyte formation has 
been found.
The characteristic delayed differentiation and continued proliferation of SHF progenitors are 
regulated by FGF, Hedgehog and canonical Wnt/β- catenin signaling pathways. Fgf8 has 
been identified as a necessary signaling molecule for SHF deployment as evidenced by the 
observation that conditional ablation of Fgf8 in mesoderm results in formation of hearts that 
are without a right ventricle or outflow tract.46 Other FGF family members involved in SHF 
development include Fgf1047 and Fgf3.48 Shh is expressed in adjacent pharyngeal endoderm 
and is required for SHF proliferation.49 Interestingly, Shh has been shown to activate a set 
of forkhead-containing transcription factors including Foxa2, Foxc1 and Foxc2, which then 
activate Tbx1.50, 51 Tbx1 in turn is critical for activation of Fgf3, Fgf8 and Fgf10, and for 
suppression of Mef2c and SRF.46, 47, 52–54 Canonical Wnt/β- catenin pathways activate 
proliferation in SHF cells in mouse embryos and also promote maintenance of multipotency 
of Isl1+ progenitors derived from ES cells.43, 55
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Neural Crest and Proepicardial Contributions
Other cell lineages also contribute significantly to heart development alongside the first and 
second heart fields. Classically, the postotic neural crest has been described to give rise to a 
population of cells, known as the cardiac neural crest, that migrate from the neural tube in a 
dorsolateral fashion to reach the caudal pharyngeal arches, from where they continue on to 
migrate into the cardiac outflow tract.56 These cells are responsible for establishing the 
aorticopulmonary septum, which divides the outflow tract into the aorta and pulmonary 
artery, and give rise to the smooth muscle cells in the tunica media of both vessels in the 
distal region of the arterial pole.29, 57 Recently, Arima et al. have demonstrated that the 
preotic neural crest also contributes to the conotruncal region and interventricular septum.58 
In addition, Escot et al. have identified SDF1 as a chemotactic agent driving the cardiac 
neural crest cell migration towards the pharyngeal arches.59 Further, Holler et al. observed a 
marked reduction in the neural crest-derived cells found in the outflow tract following loss 
of Hand2 expression in murine embryos.60 Ablation of these cells results in persistent 
truncus arteriosus, arterial pole alignment defects, and aberrant myocardium calcium 
transients stemming from elevated Fgf8 expression, which normally appears to be 
modulated by the cardiac neural crest cells.61 In addition, cardiac neural crest will contribute 
the autonomic and sensory innervation of the heart. Anomalies involving the cardiac neural 
crest cells are of clinical interest as they are responsible for a multitude of human 
cardiocraniofacial defects, such as DiGeorge Syndrome (DGS) and velocardiofacial 
syndrome (VCFS) due to the loss of Tbx1 in the context of 22q11 deletion.62 The 
deployment of cardiac neural crest cells in a coordinated fashion and their dependence on 
exchanges of signal with SHF cells is highlighted by the requirement of Jagged-1/Notch 
signaling in the SHF cells to regulate Fgf8 expression that is essential for cardiac neural 
crest cell migration and endothelial-mesenchymal transition. The exogenous replacement of 
Fgf8 appears to rescue the developmental defect in explant assay of endocardial 
cushion.63, 64
Cells of the proepicardial organ migrate to cover the surface of the developing heart. Though 
little is known about the molecular drivers of this migration, studies in mouse embryos 
suggest that the interplay between the α4 integrins and vascular adhesion molecule 1 
(VCAM-1) is essential in maintaining the epicardial lining after embryonic day 11.65, 66 
Some of these cells undergo an epithelial-to-mesenchymal transition and invade the 
underlying myocardium. Del Monte et al. have shown that Notch1 activity may play a 
critical role in this process by promoting blood vessel progenitor migration through the 
compact myocardium.67 These cells then differentiate into cardiac fibroblasts and vascular 
smooth muscle cells of the coronary vessels.68, 69 Specific subpopulations from within the 
proepicardium may also contribute to coronary endothelium.70 Interestingly, two studies 
report the differentiation of epicardial cells into cardiomyocytes,71, 72 however, significant 
controversies exist in this area. For additional discussion, the readers are encouraged to 
review articles that cover these lineages in greater detail.73–76
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Specification of Chamber Myocardium
The cardiomyocytes that make up the linear heart tube are termed “primary myocardium” 
based on their slow proliferation rate, limited automaticity, slow conduction velocity and 
poor contractility.77, 78 The cardiomyocytes that make up the outflow tract, inner curvature, 
atrioventricular canal and sinus horns retain this primary phenotype. As atrial and 
ventricular cells selectively proliferate and differentiate, “ballooning” of the outer curvature 
of the heart tube occurs. The linear heart tube’s peristaltic pumping may drive this 
ballooning process, as endocardial and myocardial cells alter their shape, size, and 
proliferation in response to mechanical stress from blood flow and contraction.79–81 The 
atrial and ventricular cells obtain a chamber myocardium identity, with associated fast 
conduction velocity, increased automaticity, increased contractility and enhanced sarcomere 
organization.82
Multiple transcription factors have been shown to regulate cardiac chamber morphogenesis 
including the T-box transcription factors Tbx2, Tbx3, Tbx5 and Tbx20 as well as Nkx2-5, 
Gata4, Cited1, Irx4, Irx1/Irx3/Irx5 and Hand1 (Figure 5). Tbx5 and Tbx20 act in 
combination with Nkx2-5 and Gata4 to promote specification of chamber myocardium, 
which includes induction of atrial natriuretic factor (encoded by Nppa), gap junction 
proteins connexin 40 (Cx40) and connexin 43 (Cx43) as well as the cytoskeletal protein 
Chisel (encoded by Smpx).4, 82, 83 Additionally, Tbx5 cooperates with Nkx2-5 to regulate 
expression of the transcriptional repressor Id2, which contributes to patterning of the right 
and left ventricular bundle branches.84, 85 The multiple roles of Tbx5 are consistent with the 
varied cardiac phenotypes observed in patients with Holt-Oram syndrome.86 In contrast, 
Tbx2 and Tbx3 can also interact with Nkx2-5 and Gata4 to repress chamber 
specification.87, 88 Suppression of chamber specification by Tbx3 allows for the expression 
of the pacemaker channel HCN4 in cells at the sinoatrial junction that will give rise to the 
sinoatrial node.85, 89
Regions of chamber versus primary myocardium are exquisitely regulated by overlapping 
regions of these various T-box transcription factors, leading to the proposed T-box code 
hypothesis.1 Whereas Nkx2-5 and Gata4 are highly expressed throughout the linear heart 
tube, the T-box transcription factors have more narrow expression patterns.78, 83 As a result 
of retinoic acid signaling, Tbx5 is expressed in a graded fashion with peak expression 
caudally in the area of the inflow tract and primitive atrium with diminished expression in 
the primitive ventricle and absence in the outflow tract.86, 90 Tbx2 and Tbx3 are expressed in 
the primary myocardium of the outflow tract, inner curvature, AV canal and inflow tract, 
with Tbx2 expression extending more rostrally compared to Tbx3.78 Tbx2 has been shown to 
inhibit proliferation and suppress expression of chamber myocardium-specific genes 
including Cx40, Cx43, Smpx and Nppa.87, 91 Notably, Tbx20 is broadly expressed 
throughout the linear heart tube and deletion of Tbx20 in mice results in defects in chamber 
development, at least in part due to expansion of Tbx2 expression (Figure 5).92–95
Within the chamber myocardium, each of the four chambers is marked by unique gene 
expression patterns. The mouse atria and ventricles express myosin light chain isoforms 
MLC2a and MLC2v, respectively.96 Both ventricles additionally express the homeobox gene 
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Irx4, which activates ventricular myosin heavy chain 1 (MHC1) and suppresses the atrial 
MHC1 isoform in chick.97 In both mouse and chick, Tbx5 expression is absent in the right 
ventricle.86 In chick, the right ventricle is also distinguished by Tbx20 expression, which the 
left ventricle lacks.35 The basic helix-loop-helix transcription factors eHAND and dHAND 
are expressed in the systemic and pulmonary ventricles, respectively, even in situs inversus 
mouse embryos.98 In atrial development, high expression of the homeobox gene Pitx2 in the 
left atrium suppresses Shox2, thereby inhibiting genes associated with sinoatrial node 
development and preventing ectopic pacemaker specification.99
Trabeculation of the Ventricular Myocardium
Trabeculation and subsequent compaction of the ventricular myocardium facilitate septation, 
confer greater contractility and conductivity, and help establish the coronary circulation 
system in the developing heart.100–104 Paracrine signaling between the endocardium and the 
maturing myocardium is an essential driver for the formation of the organized muscular 
ridges lining the ventricular wall (Figure 6), a process initiated towards the end of cardiac 
looping.105
Central to endocardium-to-myocardium regulation of trabeculation is the transmembrane 
receptor Notch1.101, 106 When the extracellular domain of Notch1 binds to ligands such as 
Delta4 and Jagged, proteolytic cleavage releases the intracellular domain (N1ICD) into the 
cytoplasm.107 N1ICD then associates with its transcriptional cofactor RBPJK and 
translocates to the nucleus108, 109 N1ICD/RBPJk upregulates myocardial expression of 
BMP10, which stimulates proliferation by decreasing the activity of cell cycle inhibitor 
P57kip2 and by up-regulating Tbx20 and Hey2 activity.110, 111 Since Notch1 is 
predominantly expressed in endocardial cells lining the base of trabeculae at E9.0, Notch 
activity therefore promotes growth of the trabecular myocardium.101 Endothelial-specific 
ablation of a N1ICD inhibitor, Fkbp1a, accordingly results in hypertrabeculation.112 
Curiously, inactivation of Mib1, an ubiquitinase that promotes ligand binding and 
subsequent activation of Notch1, in the myocardium also leads to hypertrabeculation. 
Additionally, Mib1-deficient mice have an abnormally thin compact myocardial zone.113 
The apparently contradictory effects of Notch1 regulator manipulation suggest that Notch1 
plays a complex role in spatiotemporal regulation of trabecular growth.
Notch1 signaling also promotes neuregulin-1 (Nrg1) activity through EphrinB2.101 Nrg1, 
one of the endothelial growth factors produced by the endocardium, binds to myocardial 
tyrosine kinase receptor ErbB4 and leads to its dimerization with ErbB2, thus activating 
signaling cascades modulating cell growth and migration114. Nrg1, ErbB4, and ErbB2 null 
mice die in utero around E9.5–10.5 due to embryonic heart failure, with histological 
analyses revealing ventricular chambers lacking trabeculae.115–118 Liu et al. have identified 
ErbB2 as a dual factor in cardiomyocyte proliferation and directional delamination during 
ventricular trabeculation.117 Their assessment of the cardiac function in ErbB2 mutants 
revealed decreased ventricular cardiac contractility and bradycardia, supporting previous 
reports that Nrg1/ErbB2/4 signaling modulating trabeculae formation may play an important 
physiological role in cardiac contractility.119 Additionally, high-resolution imaging of 
cardiomyocytes in zebrafish embryos suggests that ErbB2 contributes to robust formation of 
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cardiomyocyte surface protrusions and contacts between non-neighboring cardiomyocytes, 
which may be required for initiating trabeculation.120 Intriguingly, EphrinB2 expression is 
altered by shear stress in embryonic stem cells in vitro, suggesting that trabeculation may 
simultaneously contribute to cardiac contractility while responding to the consequential 
increase in blood flow.121 This interdependence between cardiogenesis, blood flow, and 
other embryonic processes presents challenges for experimental design.
Growth factor signaling from the myocardium to the endocardium also plays an essential 
role in sustaining trabeculation: mice that lack expression of Angiopoietin-1, the primary 
ligand produced in the myocardium for the endocardial Tie2 receptor, display ventricular 
morphology similar to that of the Neuregulin/ErbB4 mutants with further aberrant 
phenotypes such as defective angiogenesis, a less intricately-folded immature endocardium, 
and embryonic lethality at E12.5.122 Vascular endothelial growth factor (VEGF) is also 
produced in the myocardium and binds to the endocardial receptor Flk1. Flk1-deficient mice 
lack some endothelial lineages and therefore do not form trabeculae, causing embryonic 
lethality by E9.5.106, 123–125 Conversely, overexpression of VEGF results in an attenuated 
compact zone and hypertrabeculation.126
The modes of communication between the endocardium and myocardium may be moderated 
or complemented by the cardiac jelly, the extracellular matrix between the two layers. 
Beginning at E7.5 in the normal embryo, expression of hyaluronic acid synthase-2 (Has2) 
contributes to formation of the extracellular matrix, while global Has2 deficiency manifests 
as compact ventricular walls lacking trabeculation.127 A potential mechanism through which 
Has2 regulates trabeculation is offered by the example of Has2 activation of ErbB2/3 in 
cushion mesenchyme formation.128 In later stages of normal cardiac development, the 
metalloproteinase ADAMTS1 is highly expressed during E12.5–14.5.129 During this time, 
ADAMTS1 eliminates cardiac jelly by cleaving versican, an extracellular matrix 
proteoglycan.129, 130 Since versican appears to promote trabecular proliferation, ADAMTS1 
expression thereby signals the conclusion of trabecular growth.130 Based on investigations 
of similar versican cleavage activity in other embryonic processes, versican proteolysis not 
only disrupts functions served by intact versican but may also unmask distinct 
morphogenetic functions of the resulting fragments.131, 132 Cleavage of versican by 
ADAMTS1 is facilitated by fibulin-1, another extracellular matrix protein that binds both 
ADAMTS1 and versican, and global deletion of ADAMTS1 or fibulin-1 results in 
hypertrabeculation.129, 130 Endocardial-specific loss around E9.0 of Brg1, an ADAMTS1 
inhibitor, allows ADAMTS1 to prematurely thin the cardiac jelly and terminates 
trabeculation.129
The development of the cardiac conduction system provides an additional example of 
cardiac jelly-mediated endocardium-to-myocardium signaling in relation to trabeculation. 
Recent work suggests that endocardial signals promote Cx40 expression in the myocardium 
and that the cardiac jelly reduces the intensity of these molecular signals. This model is 
supported by the observation that the atrioventricular junction, where the endocardium and 
myocardium are separated by relatively thick cardiac jelly during valve formation, has low 
Cx40 expression and delayed conduction through the atrioventricular node.133 Endocardial 
promotion of connexin expression may also explain why the peripheral ventricular 
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conduction system, marked by Cx40 in the mature heart, forms from trabecular 
cardiomyocytes closest to the endocardium.134
To further support the interdependence of trabeculation and cardiac conduction system 
development, three recent reports have identified mutations in either ion channel HCN4 or 
ryanodine receptor RYR2 in comorbid cases of left ventricular non-compaction and certain 
familial arrhythmias.135–137 Whereas earlier surveys of LVNC patients suggested that the 
non-compact phenotype was arrhythmogenic, these reports motivate further investigation 
into the mechanisms by which HCN4 and RYR2, genes previously associated with 
arrhythmic disorders, may also perturb myocardial structure.138
Epigenetic Regulation of Heart Development
Acting in concert with signaling pathways and transcription factors, several epigenetic 
factors play a critical role in modulating cardiac lineage specification and cardiac 
morphogenesis during development. Included in the category of epigenetic regulators are 
histone modifications, ATP-dependent chromatin remodeling complexes and DNA 
methylation. Each of these regulatory modes influences gene expression by modulating the 
accessibility of regulatory DNA sequences to DNA binding proteins, such as transcription 
factors. As a result, epigenetic regulation adds an additional layer of complexity to the tight 
temporal and spatial control of cardiac gene expression during development.
Covalent modifications to histone proteins alter DNA-histone interactions, resulting in the 
establishment of looser or more accessible versus tighter or more restricted chromatin. 
Histone acetylation primarily promotes chromatin accessibility, thereby leading to 
transcriptional activation. The specific role of histone acetyltransferases (HAT) in heart 
development is still unclear. However, mice who carry a global loss-of-function mutation in 
the HAT gene p300 die between E12.5 and E15.5, possibly due to the development of 
severe heart defects.139 Interestingly, this effect may be due to acetylation and activation of 
Gata4 by p300.140 In addition, mice globally lacking the HAT Moz show aortic arch 
abnormalities and ventricular septal defects similar to those found in 22q11 deletion 
syndrome due to decreased acetylation and therefore transcription of Tbx1.141, 142 In 
contrast to HATs, histone deacetylases (HDACs) remove acetyl groups from histones, 
resulting in formation of condensed chromatin and transcriptional repression. Cardiac-
specific loss of either Hdac1 or Hdac2 has no significant effect while double mutants 
lacking both Hdac1 and Hdac2 in myocardium die in the neonatal period due to cardiac 
arrhythmias and dilated cardiomyopathy.143 The deacetylase activity of these epigenetic 
factors may not be limited to histone modification. For example, Hdac2 is thought to limit 
myocardial proliferation via a partnership with Hopx (homeodomain-only protein) that 
results in deacetylation of Gata4, thereby decreasing its transcriptional activity.144, 145 
Similarly, Hdac3 may suppress Tbx5 activity by altering acetylation of Tbx5 residues.146
In contrast to histone acetylation, the effect of histone methylation is highly residue-specific, 
with methylation of histone H3 at lysine 4, 36 and 79 leading to gene activation while 
methylation at lysine 9 and 27 generally results in gene silencing. Both histone 
methyltransferases and demethylases have been shown to play critical roles in cardiac 
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development, and de novo mutations in genes associated with regulation of histone 3 lysine 
4 and lysine 27 methylation have been detected in excess in children with non-familial 
congenital heart disease.147 Loss of the histone methyltransferase Smyd1 results in right 
ventricular hypoplasia, possibly due to diminished expression of key cardiac transcription 
factors Hand2 and Irx4.148 Jarid2, a member of the Jumonji family of histone demethylases, 
is a key regulator of cardiac trabeculation (discussed in the preceding section) via repression 
of endocardial Notch and Nrg1.149
ATP-dependent chromatin remodeling complexes harness energy from ATP hydrolysis to 
alter nucleosome packaging, and thus DNA accessibility.140 Of the four families of ATP-
dependent chromatin remodelers, the family best studied in cardiac development is the 
switching defective/sucrose non-fermenting (SWI/SNF) family. The Brg1/BRM-associated 
factor (BAF) complex contains twelve subunits, including the ATPase subunit encoded by 
either brahma (Brm) or brahma-related gene 1 (Brg1).150 Brg1 has been shown to 
genetically interact with several cardiac transcription factors, including Nkx2-5, Gata4, Tbx5 
and Tbx20.151, 152 Mice that are globally haploinsufficient for Brg1 show a wide range of 
mild cardiac defects, including mild septal defects and aberrant conduction. Interestingly, 
mice with both haploinsufficiency for Brg1 as well as haploinsufficiency for Nkx2-5, Tbx5 
or Tbx20 show more severe and often lethal cardiac defects than single mutants 
alone.153–155 Brg1 also promotes myocardial proliferation through stimulation of Bmp10, 
and the thin myocardium phenotype observed in the absence of Brg1 can be rescued with 
Bmp10.156 Also of note, murine Brg1 activates fetal beta-myosin heavy chain while 
repressing adult alpha-myosin heavy chain, thereby maintaining a fetal phenotype during 
development.156 Finally, perhaps the most striking evidence demonstrating a central role for 
chromatin remodeling in cardiomyocyte lineage specification is the observation that 
overexpression of Tbx5, Gata4, and the BAF subunit Baf60c can promote 
transdifferentiation of non-cardiac mesoderm into cardiac tissue.157
DNA methylation involves the addition of a methyl group to cytosine in so-called CpG 
islands. Notably, DNA methylation patterns are wiped clean at the time of conception and 
are gradually re-introduced during embryogenesis. Recent genome-wide analysis of DNA 
methylation patterns in developing mouse hearts demonstrated overall stability in the 
amount of DNA methylation between E11.5 and E14.5.158 However, less than 1% of 
methylation sites did show differential methylation patterns between the two time-points, of 
which about two-thirds were more highly methylated at E14.5.158 Cardiac regulatory genes 
were highly enriched in this subset, including signaling molecules such as Wnt2 and Fgf2 as 
well as transcription factors such as Gata6 and Mef2c.158 Among those sites with the 
greatest amount of differential methylation, half also showed corresponding changes in 
expression of the associated gene.158
Summary
As our understanding of the molecular regulation of cardiac development continues to 
improve, so will our ability to clarify the determinants of congenital heart disease as well as 
our capacity to generate cells for regenerative medicine therapies. In recent years, the 
identification of key transcription factors and their requirement in distinct stages of 
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cardiomyogenesis has helped lay the groundwork for determining the precise molecular 
mechanism involved in commitment of cardiac progenitor cells from their mesodermal 
precursors, chamber-specific cardiomyocytes from heart field progenitors, and trabecular 
versus compact myocardium from chamber myocytes. Furthermore, the elucidation of 
critical epigenetic modifiers that regulate expression of cardiac genes in a spatiotemporal 
manner has helped reveal essential mechanisms that modify chromatin at specific locations 
for transcription factors to execute their designated roles during development.
Future Perspectives
In order to realize the tremendous potential made by our cumulative investment in cardiac 
development biology in recent decades to identify the pathogenic mechanisms of congenital 
heart diseases such as hypoplastic left heart syndrome, transposition of great vessels, double 
outlet right ventricle, and ventricular non-compaction, further clarification is needed on a 
number of key unresolved issues. For example, with regards to the understanding of heart 
field precursor commitment, we need greater insight into the differences in epigenetic 
regulation between FHF and SHF cells as they may explain the differences in the response 
to failure between the right and left ventricle. Specifically, the lack of requirement for Isl1 
expression in FHF cells and the differential effects of FGF and BMP signaling in SHF cells 
suggest that the biology of right ventricular cardiomyocytes at the single cell level may be 
very different from those in the left ventricle.
In the formation of chamber-specific cardiomyocytes, the distinct expression of T-box and 
Hand transcription factors along the linear and looping heart tube suggest differences in 
epigenetic regulation between atrial versus ventricular, as well as right versus left ventricular 
myocyte development. It would be of great value to elucidate the gene expression and 
epigenetic profile of all chamber myocyte precursors during the linear heart tube stage of 
development at the single cell level. This level of resolution could help us determine the key 
regulators at the earliest steps of chamber myocyte formation and their link to chamber-
specific malformations.
Finally, in the context of trabecular versus compact myocardium formation for chamber-
specific myocytes, we need a greater understanding of the role of specific signaling pathway 
and biomechanical influences on myocardial maturation. Identifying the answers to these 
questions may hold the key to our ability to accurately predict and diagnose congenital heart 
diseases and treat them in utero using novel interventional or molecular therapies. Indeed, 
one of the most significant barriers to translating pluripotent stem cell (PSC)-derived 
cardiomyocytes into regenerative therapies is the inability of these cells to reach full 
maturity both in vitro and in vivo after transplantation. Despite significant efforts to enhance 
the maturation of these cells by pacing, stretching, and co-culturing with non-myocytes, they 
remain largely immature. A better understanding of the key factors that regulate normal 
cardiomyocyte maturation during embryonic development should help guide, conceptually, 
the designing of new approaches to enhance the maturation of PSC-derived cardiomyocytes 
in vitro. If we are successful in this endeavor, the potential for screening and discovering 
new drugs using PSC-base disease models to treat defective signaling pathways in 
congenital heart disease could be significantly increased.
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In summary, we believe that while major strides have been made in recent years to unravel 
the molecular underpinnings of cardiomyogenic lineage commitment, expansion, and 
maturation, there remain significant gaps in our knowledge that await further investigation. 
With the continuous advancements in stem cell and genome-editing technology, as well as 
detailed mechanistic analysis using model organisms, we shall be able to identify and 
pinpoint key regulators of cardiomyogenesis and devise approaches to correct their 
functional deficiency prior to the development of disease.
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Mesp1 Mesoderm Posterior 1
BMP bone morphogenetic protein
FGF fibroblast growth factor
FHF first heart field
SHF second heart field
AV atrioventricular





VCAM-1 vascular adhesion molecule 1
Cx connexin
MHC myosin heavy chain
N1ICD Notch1 intracellular domain
Nrg1 neuregulin-1
VEGF vascular endothelial growth factor
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SWI/SNF switching defective/sucrose non-fermenting
BAF Brg1/BRM-associated factor
Brm brahma
Brg1 brahma-related gene 1
Shh sonic hedgehog
AVC atrioventricular canal
p-OFT proximal outflow tract
d-OFT distal outflow tract
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Figure 1. Overview of heart development
The cardiac crescent consisting of the first and second heart field cardiac progenitors is 
established during late gastrulation. The subsequent proliferation and differentiation of cells 
in the first heart field (FHF) leads to the formation of a linear heart tube, giving rise 
primarily to the left ventricle and a portion of the atria. The cardiac progenitors in the 
anterior second heart field (SHF) contribute to the right ventricle and the outflow tract while 
the posterior SHF cells give rise to the atria and the inflow tract.159 Extension and rightward 
looping of the linear heart tube allow cranial positioning of the atria with respect to the 
ventricles. Remodeling events modulate chamber formation, septation, and valve 
development, resulting in formation of the four-chambered heart. Transcription factors that 
regulate each stage of heart development are listed. FHF and its derivatives are shown in 
orange. SHF and its derivatives are shown in blue.
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Figure 2. Regulation of cardiac mesoderm specification
Shown is a cross-section of an E7.5 mouse embryo detailing the signaling pathways that 
regulate cardiac specification within splanchnic mesoderm. Factors secreted by the adjacent 
endoderm that support cardiac mesoderm specification include FGF, BMP and Shh. 
Additionally, non-canonical Wnt ligands, such as Wnt11, expressed in splanchnic mesoderm 
also promote cardiac differentiation. Conversely, canonical Wnt ligands, including Wnt1, 
Wnt3a and Wnt8, secreted from the overlying neuroectoderm as well as BMP antagonists 
Noggin and Chordin secreted from the notochord inhibit cardiac mesoderm specification, 
thereby limiting the size of the cardiogenic fields. Abbreviations: FGF, fibroblast growth 
factor; BMP, bone morphogenetic protein; Shh, sonic hedgehog.
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Figure 3. Schematic of cardiovascular lineage diversification
The specification of cardiomyocytes in the first and second heart fields is shown in the 
context of other cardiac cells that also derive from a common cardiogenic mesoderm 
progenitor. In particular, Isl1 expression distinguishes the first and second heart fields. 
Comparison of action potentials for mature myocytes reveals the range of function generated 
from each heart field. *Developmental origin of the coronary endothelium is an active topic 
of investigation. While some evidence points to partial contributions to the coronary 
endothelium from the epicardium70, 160, other sources such as the endocardium161 and the 
sinus venouses69 have also been reported.
Paige et al. Page 25













Figure 4. Cardiac gene regulatory network
The diagram shown is a brief overview of a subset of all known transcription factor 
interactions and signaling pathways that drive the differentiation of FHF (orange) and SHF 
(blue) cardiac progenitor cells during development. Factors colored by both orange and blue 
represent regulators of both FHF and SHF. Arrows indicate increased expression of one 
transcription factor or signaling molecule due to activity of another transcription factor. 
Signaling pathways that activate expression of certain transcription factors are shown in red.
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Figure 5. Specification of chamber myocardium
The specification of cells to the chamber myocardium is modulated by Tbx5 and Tbx20 in 
tandem with more broadly expressed factors Nkx2-5 and Gata4. Tbx2 and Tbx3 suppress 
the expression of chamber myocardium-specific genes, resulting in low proliferation rate, 
slow conduction velocity, and poor contractibility characteristic to the primary myocardium. 
The primary myocardium phenotype becomes restricted to the AVC and p-OFT. 
Abbreviations: AVC, atrioventricular canal; p-OFT, proximal outflow tract; d-OFT, distal 
outflow tract.
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Figure 6. Spatiotemporal regulation of trabeculation
The development of ventricular trabeculae is governed by signal transduction involving the 
endocardium, myocardium, and cardiac jelly. Pathways implicated in trabeculation are 
depicted in approximate chronological order of expression from left to right. Beginning with 
establishment of the cardiac jelly and endothelium, trabeculation progresses via cellular 
proliferation and migration, and ends with degradation of the cardiac jelly. Factors involved 
in epigenetic mechanisms are underlined.
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